Costs Of Gastroenteritis Research Articles

Cost of gastroenteritis in Australia: A healthcare perspective.

BackgroundAcute gastroenteritis illness is a common illness that causes considerable morbidity, but current estimates of the cost to the Australian healthcare system are unknown.ObjectiveTo estimate the current healthcare utilisation and direct public healthcare system costs attributable to acute gastroenteritis illness in Australia.MethodsThis is an incidence-based cost-of-illness study focused on quantifying direct health care costs using a bottom-up approach. Data on general practitioner consultations, prescribed medications, diagnostic tests, specialist consultations, emergency department visits and hospital admissions were collected from national reports.ResultsUsing 2016 prices, the estimated annual direct per capita cost of acute gastroenteritis illness was AUD$14.87 (USD$10.71), equating to AUD$20.27 (USD$14.59) per case. The estimated overall economic burden in Australia was AUD$359 million (USD$258 million; AUD$1.5 million per 100,000 people). The major contributors to this cost were hospital admissions (57.1%), emergency department visits (17.7%), and general practitioner consultations (14.0%). Children under five years of age have the highest per capita rates of acute gastroenteritis illness; however, service utilisation rates vary by age group and both young children and older adults accounted for a substantial proportion of the overall economic burden attributable to acute gastroenteritis illness.ConclusionsAlthough chronic diseases comprise a large cost burden on the healthcare system, acute illnesses, including acute gastroenteritis illness, also impose substantial direct healthcare system costs. Providing data on current cost estimates is useful for prioritizing public health interventions, with our findings suggesting that it would be ideal if targeted interventions to reduce hospitalisation rates among young children and older adults were available.

Costs of gastroenteritis in the Netherlands, with special attention for severe cases

In 1999, the costs of gastroenteritis in the Netherlands were estimated using data on hospitalizations from national registries, together with data on etiology and self-reported data on health care resource use in a community-based study. Now, more information on hospitalizations is available and these data were used to update the total costs of gastroenteritis in the Netherlands. The costs of severe gastroenteritis in the Netherlands were estimated in more depth using a hospital-based study, with patient questionnaires including a follow-up period of 6 months. The overall costs of gastroenteritis were calculated taking direct medical costs, direct non-medical costs, and indirect non-medical costs into account. The costs for severe gastroenteritis in 2009 were estimated at <euro>2,203 per hospitalized child and <euro>6,834 per hospitalized adult. The overall costs of gastroenteritis in 2009 were estimated at <euro>611-695 million, which is <euro>133-151 per gastroenteritis case or <euro>37-42 per inhabitant. The total health care costs for gastroenteritis were about 50% higher in 2009 compared to 1999, which is mostly due to the rise in health care costs. The costs per gastroenteritis episode in adults are higher compared to children, mainly due to differences in the reasons for hospitalization and course of disease, and productivity losses.

Burden and Cost of Gastroenteritis in a Canadian Community

This study estimated the health burden and costs associated with gastroenteritis in the City of Hamilton (Ontario, Canada). The number of cases, number of different resource units used, and cost per resource unit were represented by probability distributions and point estimates. These were subsequently integrated in a stochastic model to estimate the overall burden and cost in the population and to depict the uncertainty of the estimates. The estimated mean annual cost per capita was Can$115. The estimated mean annual cost per case was Can$1,089 and was similar to other published figures. Gastroenteritis represented a significant burden in the study population, with costs high enough to justify prevention efforts. These results, currently the most accurate available estimates for a Canadian population, can inform future economic evaluations to determine the most cost effective measures for reducing the burden and cost of gastroenteritis in the community.

Costs of gastroenteritis in The Netherlands.

In order to target the most important cost components of gastroenteritis in The Netherlands and to indicate which change of policy yields the largest decrease in costs, the cost of illness of gastroenteritis and the number of Disability Adjusted Life Years (DALYs) in the Dutch population in 1999 were determined. The costs of gastroenteritis were estimated using data mainly from a community-based cohort study. For calculating DALYs, data on the number of deaths due to gastroenteritis were used from Statistics Netherlands. On average, the costs for gastroenteritis were 77 Euro (euros) per case. For all patients in The Netherlands, the costs were estimated at 345 million euros (ranging between 252 and 531 million euros). Indirect costs made up 82% of this total. An estimate of costs for patients with campylobacter, salmonella or norovirus infections was, in total, 10-17% of the costs of gastroenteritis. Gastroenteritis was associated with a loss of approximately 67,000 DALYs.

Cost of community gastroenteritis.

Gastroenteritis is a common illness that causes considerable morbidity in developed countries. Endemic gastroenteritis that is not associated with outbreaks causes the greatest number of cases, but information is limited about the burden of this disease, and the resources required to manage its impact on society. In the present study, we estimated the rate of endemic gastroenteritis, the number of visits to the local doctor, use of medication, and the cost of gastroenteritis in Australia. Data from a community-based study of gastroenteritis, a general practice surveillance network, the Australian Bureau of Statistics and the Health Insurance Commission were used to measure endemic gastroenteritis and other study outcomes. The results were then extrapolated to the Australian Community. There were an estimated 0.8 cases of gastroenteritis per person per year in Australia. This equated to 15,173,430 cases of gastroenteritis in Australia annually. The age-standardized estimate of the total number of visits to the general practitioner (GP) for gastroenteritis was 1024,214 at a cost of 26,722,691 Australian dollars. The average cost of prescribed medication per visit was 6.83 Australia dollars; the estimated total cost of prescribed medication was 6995,381 Australian dollars. The estimated cost of over-the-counter medication was 14,587,477 Australia dollars. It was estimated that people working full or part-time had 0.13 days-off per person per year because of gastroenteritis, at a cost of 137,924,170 Australian dollars. The estimated total cost of endemic gastroenteritis in Australia was 342,855,616 Australian dollars of which 75,908,274 Australian dollars was direct medical costs and 266,947,342 Australian dollars was time costs and the costs for time off work to care for a sick family member. Endemic gastroenteritis is an important illness in both developed and developing countries. Although in developed countries, the majority of individual cases are mild to moderate in their severity; the overall costs are significant. The results highlight the need for ongoing research to identify the main causes of endemic gastroenteritis.